Status:
COMPLETED
Outcome of Idiopathic Macular Hole
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Idiopathic Macular Hole
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).
Eligibility Criteria
Inclusion
- Patients with with stage 2, 3, or 4 Idiopathic Macular Hole after successful Idiopathic Macular Hole repair
Exclusion
- All patients without stage 2, 3, or 4 Idiopathic Macular Hole repair
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00941291
Start Date
January 1 2002
End Date
January 1 2005
Last Update
July 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Unit CHU Dijon
Dijon, Burgundy, France, 21000